NYSE:TEVA Teva Pharmaceutical Industries Q2 2026 Earnings Report $31.36 +0.36 (+1.15%) Closing price 07/21/2026 03:59 PM EasternExtended Trading$31.12 -0.23 (-0.73%) As of 06:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Teva Pharmaceutical Industries EPS ResultsActual EPSN/AConsensus EPS $0.08Beat/MissN/AOne Year Ago EPSN/ATeva Pharmaceutical Industries Revenue ResultsActual RevenueN/AExpected Revenue$4.05 billionBeat/MissN/AYoY Revenue GrowthN/ATeva Pharmaceutical Industries Announcement DetailsQuarterQ2 2026Date7/29/2026TimeBefore Market OpensConference Call DateWednesday, July 29, 2026Conference Call Time8:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Teva Pharmaceutical Industries Earnings HeadlinesTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Average Rating of "Moderate Buy" from Analysts2 hours ago | americanbankingnews.comTeva on track to snap seven straight sessions of lossesJuly 16, 2026 | msn.comYour First Trade Playbook is expiringMost beginners stay stuck on the sidelines for years because no one shows them the simple steps between being interested in options and actually placing a trade. Your First Trade Playbook closes that gap in one evening - and right now it is still free. Bill Poulos plans to charge for it soon, so download your copy before the temporary link expires.July 22 at 1:00 AM | Profits Run (Ad)J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook RaisedJuly 15, 2026 | finance.yahoo.comTeva Pharmaceutical Industries (TEVA) Could Be 21% Below Fair Value On Vitiligo Trial ProgressJuly 14, 2026 | finance.yahoo.comDeckers Brands Announces Conference Call to Review First Quarter Fiscal 2027 Earnings ResultsJuly 13, 2026 | finance.yahoo.comSee More Teva Pharmaceutical Industries Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Teva Pharmaceutical Industries? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teva Pharmaceutical Industries and other key companies, straight to your email. Email Address About Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries (NYSE:TEVA) (NYSE:TEVA) is an Israeli multinational pharmaceutical company and one of the world’s largest manufacturers of generic medicines. The company’s core activities include the development, production and marketing of generic pharmaceuticals alongside a portfolio of specialty branded medicines. Teva supplies finished dosage forms and active pharmaceutical ingredients (APIs) to markets around the globe and operates manufacturing and research facilities in multiple countries. Teva’s product range covers oral solids, injectables, inhalation products and other dosage forms across therapeutic areas such as central nervous system disorders, respiratory, oncology, pain and infectious disease. Its specialty portfolio is best known for Copaxone (glatiramer acetate), a long‑standing therapy for multiple sclerosis, while the broader business includes complex generics, emerging biosimilars, innovative formulations and pipeline programs. The company also offers contract manufacturing, licensing and distribution services and maintains R&D capabilities focused on generic product development and targeted specialty therapeutics. Headquartered in Petah Tikva, Israel, Teva has grown through a combination of organic expansion and acquisitions and serves customers across North America, Europe, Latin America, Asia Pacific and other regions. The company is overseen by a board of directors and an executive management team responsible for global operations, regulatory compliance and commercial strategy. Teva’s strategic priorities include scaling its generic offerings, advancing selected specialty programs and pursuing operational efficiencies to support its extensive international footprint.View Teva Pharmaceutical Industries ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 3M's Redemption Arc: Can Q2 Earnings Change the Narrative?Alphabet Is Planning a New AI Chip. Here's Why It Matters Ahead of EarningsConfidence Is Back, But Earnings Show the Consumer Is Being PickyIndustrial and Utility Giants Boost Dividends as Data Center Tailwinds BuildIREN’s $2.8 Billion AI Contract Haul Changes the Stock’s StoryBuy, Hold, or Wait: 3 Small-Cap Stocks Telling Different StoriesIs Domino's Stock Serving Up a Buying Opportunity? Upcoming Earnings RTX (7/23/2026)Lockheed Martin (7/23/2026)Newmont (7/23/2026)Intel (7/23/2026)Nokia (7/23/2026)Relx (7/23/2026)SAP (7/23/2026)STMicroelectronics (7/23/2026)T-Mobile US (7/23/2026)Comfort Systems USA (7/23/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
